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Abstract. Background/Aim: Breast cancer treatment
represents a substantial amount of health-care costs and has
negative impact on womens’ psychological health. Day-
Surgery managment (DS) is a favorable alternative to a
classic inpatient setting. In our prospective study we
evaluated DS-treatment feasibility in terms of patient
satisfaction, same-day-discharge rate, surgical-
reintervention rate, psychological impact and costs. Patients
and Methods: We operated on 131 early breast cancer
patients in DS. Surgical outcomes were evaluated. In 64 DS-
treated breast cancer patients, psychological outcomes were
analyzed using validated psychometric questionnaires and
comparison was made with a corresponding group of women
treated as inpatients. Results: The same-day-discharge rate
was 95.4%. No patient required readmission. The surgical-
reintervention rate was 6.2%. DS-treatment significantly
reduced anxiety (p=0.05) and depression (p=0.01) and
afforded cost savings of 49%. Conclusion: DS-treatment of
early breast cancer was feasible, with low reintervention
rate, reduced anxiety and depression, high patients’
satisfaction and substantial financial savings.
Treatment for breast cancer, which is the most common
female malignancy in developed countries, accounts for a
substantial amount of national healthcare costs. In various
countries, a heavy burden is imposed upon the health care
system due to the increase in medical care costs (1),  which
are in part due to the introduction of highly advanced
expensive drugs and costly medical technologies. However,
innovations such as the sentinel lymph node biopsy (SLNB),
in association with breast conserving surgery in early breast
cancers, have substantially reduced the impact of surgical
treatment, in terms of post-operative pain, need for surgical
drains and patient autonomy. In conclusion, a considerable
proportion of breast cancer patients may undergo
quadrantectomy with SLNB and be safely discharged from
the hospital on the very same day. In spite of this, in our
country most patients undergoing breast conserving surgery
and SLNB for treatment of early breast cancer are
hospitalized for at least one or two nights. Considering that
in most countries reimbursements are calculated on a fee-for-
service basis, according to the diagnosis-related-group
(DRG) system guidelines, it is clear that treatment for early
breast cancer in a Day Surgery setting (DS) could represent
a significant saving as it relates to cost of care (2).  
Another relevant aspect of diagnosis and treatment for
breast cancer is its dramatic negative psychological impact
upon women, secondary to the fear of either dying of disease
and/or impaired body image (3-5). The need for semi-private
accommodations with other critical oncologic patients may
further worsen psychological responses. We hypothesize that
a short hospital stay for a surgical procedure with same-day
discharge versus the standard two-three days inpatient
hospitalization, may reduce anxiety and the depressive mood
associated with diagnosis and treatment. Studies have been
done to evaluate the feasibility of same-day discharge after
breast cancer surgical treatment, none of which evaluated the
psychological outcome of such an approach, by means of
validated psychometric instruments (6). 
In this prospective study, the feasibility of same-day
discharge after early breast cancer surgical treatment was tested
in terms of patients’ satisfaction with the procedure, need for
overnight stay and reoperation. A cost-benefit analysis was
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performed in order to compare DS treatment with standard
inpatients’ surgical management in terms of health care system
costs. Furthermore, patients’ outcomes were studied in terms
of mood, anxiety and quality of life, by means of validated
psychological testing, and compared with a control group of
patients undergoing standard inpatient surgical treatment.
Patients and Methods
Patients selection. In this prospective study, we identified 131
patients with early breast cancer undergoing surgery at our Breast
Unit of the Gynaecology and Obstetrics Department, Careggi
Hospital, University of Florence and satisfying inclusion criteria for
treatment in a DS setting. DS was defined as a surgical operation
allowing patients to go home later on the very same day. Inclusion
criteria were: preoperative histological diagnosis of in situ or
invasive breast carcinoma with a diameter of <3 cm, favorable
proportion between tumor and breast size allowing for breast
conserving surgery, fairly good clinical conditions and low risk of
lymph node metastases, meaning that both clinical examination and
axillary ultrasound resulted negative. Ultrasonographic criteria for
axillary lymph node evaluation are given in detail elsewhere (7-9).
Patients operated in DS did not receive frozen section examination
of the sentinel node. All patients gave their written informed
consent. Protocol was approved by the local Ethics Committee. 
Surgical procedure. The breast surgical DS procedure consisted of
a wide local excision or a quadrantectomy with clear margins of at
least 1 cm from the tumor, associated with SLNB. It was done under
local anesthesia, using a mixture of Lidocaine hydrochloride 2% and
Ropivacaine hydrochloride 10 mg/ml. Sedation was administered
(Propofol 10 mg/ml I.V.) with mask ventilation. No surgical drain
was left in situ. Ice packing was applied postoperatively during the
first hour. All removed nodes were submitted for standard
histological testing. In cases where sentinel lymph node
macrometastases were detected at final histology, patients were
readmitted mostly to undergo axillary lymph node dissection
(ALND), which by contrast was not performed in cases where
micrometastases or isolated tumor cells (ITC) were identified. 
Questionnaries administration. We administered questionnaires to
a subgroup of 64 patients with invasive breast carcinoma treated
with breast-conserving surgery and SLNB, in order to rate their
degree of satisfaction with the procedure and post-operative pain.
The Visual Analogue Scale (VAS) (10) was used to assess pain 1
day and 7 days after the procedure. To explore the psychological
impact of the procedure, in terms of mood, anxiety and depression,
we administered specifically designed, validated questionnaires, one
week before surgery and one month after surgery. Mood was
evaluated with the 5 items "Satisfaction with Life Scale (SWLS)"
(11), anxiety with the 20 items "State-Trait Anxiety Inventory”
(STAI) (12) and depression with the 20 items “Center for
Epidemiologic Studies Depression Scale” (CES-D) (13). We then
identified a control group consisting of 64 patients matched for age,
tumor stage and clinical conditions, who underwent breast-
conserving surgery and SLNB under general anesthesia, with
traditional inpatient hospitalization for at least one post-operative
night. The same questionnaries were administrated to the control
group, with the same timing.
End points. End points of our study were: same-day discharge rate
(defined as the percentage of patients operated on and returning home
the same day of the surgical procedure), early readmission (defined as
need for readmission within 48 hours from the surgical procedure) and
reintervention rate (defined as the percentage of patients who needed
a second surgical intervention for various reasons, i.e. axillary
clearance, inadequate surgical margins, complications). 
Cost assessment. By conferring with the Business Office of the
hospital, the incurred costs were compiled for each DS procedure
and for each traditional inpatient procedure.  
Compliance with ethical standards. All procedures performed in
studies involving human participants were in accordance with the
ethical standards of the institutional and/or national research
committee and with the 1964 Helsinki declaration and its later
amendments or comparable ethical standards.
Statistical analysis. Patient characteristics were analyzed using
Fisher’s exact test or the Chi-square test, as appropriate. Results of
the psychometric questionnaires were submitted for analysis of
variance using the ANOVA test (IBM SPSS Statistics for Windows,
Version 22.0. Armonk, NY: IBM Corp.) A p-value <0.05 was
considered statistically significant.
Results
DS feasibility. We analysed 131 patients with a mean age of
62 years. Preoperative diagnosis was in situ carcinoma in 37
cases (28%) and invasive carcinoma in 94 cases (72%).
Overall, a wide local excision was performed in 112 (85.5%)
patients and a quadrantectomy in 19 (14.5%) patients. In 81
of 94 women (86%) with invasive carcinoma a SLNB was
concurrently performed. Advanced age and/or relatively poor
clinical conditions, were reasons for renouncing to SLNB in
the remaining 13 patients. Same-day discharge was feasible in
125 of 131 patients (95.4%). There were no patients requiring
early readmission for complications. Among the remaining 6
patients, 3 were hospitalized because the operation was
performed in the afternoon, although it was scheduled for the
morning hours. In 5 cases, the pathological examination
revealed an upgrade to invasive carcinoma initially diagnosed
as ductal carcinoma in situ (DCIS), therefore we had 99 cases
of invasive breast cancer (75.6%) and 32 cases of carcinoma
in situ (24.4%). Pathological features are reported in Table I.
Among the 9 positive SLN cases (macrometastases), 5
underwent subsequent ALND, 4 either refused or had
comorbidities discouraging a second surgical intervention.
Overall, among the 81 patients submitted for SLNB, 76
(93.8%) did not receive any additional surgery, while 5
patients (6.2%) underwent a second surgical procedure to
perform ALND. In 2 cases (2.4%) a widening of the breast
resection margins was concurrently performed.
Questionnaries results. Between July 2016 and July 2018,
we operated on 67 women with invasive breast carcinoma
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using breast conserving surgery and SLNB in DS setting.
They were all invited to rate their degree of satisfaction with
the procedure and to assess their emotional burden by
answering questionnaires. Two of them declined; one patient
was excluded because of language barrier. The remaining 64
patients were able to be evaluated for satisfaction, pain and
psychological aspects. Clinical and pathological
characteristics of these patients and those of the
corresponding control group are presented in Table II. Data
concerning pain are reported in Figure 1. According to the
psychometric tests, we found a statistically significant
reduction in depression and anxiety scores following DS
(p=0.01 and p=0.05, respectively) compared to women
treated in a traditional inpatient setting (Figure 2). 
Economic analysis. Costs associated with breast cancer DS
treatment and with traditional inpatient setting were evaluated.
Average cost for each DS patient was €469, compared to €999
for each one-night-inpatient case, reflecting savings of €530.
The amount saved during the study period (125 × €530=
€66250) adjusted for costs related to needed reintervention (5
× €999=€4995), was €61255, corresponding to a 49% savings
for treatment in DS.
Discussion
We found that surgical management of early breast cancer in
DS was feasible and well accepted by most patients. Our
results concerning patient satisfaction were similar to those
reported by Friedman (14) and by Goodman (15) whereas
they differed from those of Marchal who reported a higher
refusal rate (13.9%) (16). In the current study, more than
95% of patients were discharged on the same day of surgery,
as planned. Actually, only 3 patients (2.3%) were not
discharged for clinical reasons, while in another 3 cases,
patients remained in the hospital because the surgical
procedure was delayed to the afternoon hours. A different
timing of these 3 operations could have therefore raised the
same-day discharge rate to 97.7%. Overrunning theatre lists
as a cause of overnight admission have been reported also
by others (17). Nevertheless, our finding is in line with other
studies on DS management of breast cancer which reported
same-day discharge rates ranging from 86% to 100% (14-
26). However, there is one small randomized study reporting
lower rate of discharge on the same day of surgery (47%)
mainly due to axillary clearance following frozen section
evaluation of the sentinel nodes (27). In the current series,
there were no patients requiring early post-operative
readmission, as also reported by others (14-17, 20, 23),
whereas some studies reported readmission rates of 6-7%
due to post-op complications (19, 25). Pain scores did not
differ between patients operated under local anesthesia with
sedation in DS and those operated on traditionally, using
general anesthesia. More than 96% of patients reported
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Table I. Pathological features of the 131 patients with breast carcinoma
operated on in DS setting.
pT Stage                                       n˚                                      %
                                                                                                 
pTis                                               32                                    24.4
pT1a                                              11                                     8.4
pT1b                                             31                                    23.7
pT1c                                             45                                    34.3
                                                                                                 
Total                                             131                                  100.0
                                                                                                 
Histology                                                                                 
                                                                                                 
DCIS                                             28                                    21.4
LCIS                                              4                                      3.0
IDC                                               48                                    36.6
ILC                                               25                                    19.1
Mixed                                           15                                    11.4
Others                                           11                                     8.5
                                                                                                 
Total                                             131                                  100.0
DCIS: Ductal carcinoma in situ; LCIS: lobular carcinoma in situ; IDC:
Invasive ductal carcinoma; ILC: invasive lobular carcinoma; Mixed:
IDC+ILC. 
Table II. Clinical and pathological characteristics of the patients with
invasive breast cancer treated in Day surgery (DS) and in a traditional
inpatient setting (controls) and submitted for psychological testing.
                                                        DS                     Controls
                                                  n˚           %            n˚            %     p-Value
                                                                                                 
Age; Median (range)         59 (33-81)     -       59 (33-81)      -         n.s.
pT Stage                                                                                             n.s.
  1a                                            10         15.6          12          18.8         
  1b                                            14         21.9          14          21.9         
  1c                                            32         50.0          28          43.7         
  2                                               8          12.5          10          15.6         
                                                                                                 
Total                                          64        100.0         64         100.0        
Histology                                                                                           n.s.
  IDC                                         46         71.9          45          70.3         
  ILC                                         10         15.6          11          17.2         
  Mixed                                      2           3.1            3            4.7          
  Others                                      6           9.4            5            7.8          
                                                                                                 
Total                                          64        100.0         64         100.0        
Patients with chronic pain        2           3.1            1            1.6       n.s.
Performance status <80%         4           6.3            4            6.3       n.s.
IDC: Invasive ductal carcinoma; ILC: invasive lobular carcinoma;
Mixed: IDC+ILC; 
n.s.: not significant.
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Figure 1. Pain score according to the visual analogue scale (VAS) 1 (1a) and 7 days (1b) after the surgical procedure in patients operated in Day
Surgery (DS) and in  a traditional inpatient setting (controls).
Figure 2. Baseline and post-operative mean scores of anxiety (2a; 2c), according to "State-Trait Anxiety Inventory" (STAI)(12), and depression (2b;
2d), according to the Center for Epidemiologic Studies Depression Scale (CES-D scale) (13), in women treated for breast cancer in day surgery
(DS) and in a traditional inpatient setting (controls).
positive feedback about their experience in DS. Two patients
(3.1%) were not satisfied because of excessive familial
burden and anxiety related with staying at home without
medical supervision during the first night. This is in line with
the majority of previous reports on the topic (14, 19, 20, 23,
24), with the exception of the study by Margolese, in which
40% of patients would have preferred to have spent at least
one night in the hospital (28). It should be noted that a direct
comparison with this latter study is not feasible as patients
submitted for major breast surgery procedures such as
mastectomy and ALND, were also included. Our decision of
renouncing by principle to the frozen section examination of
the sentinel nodes might be questioned since it is associated
with a high risk of reintervention. However, the
reintervention rate in the current series was only 6.2%,
supporting our belief that with careful pre-operative
evaluation of the axillary lymph nodes by ultrasound and
considering further criteria of risk for axillary node
metastases (7, 9), it is possible to select breast cancer
patients with a reasonably low risk of lymph node
metastases, that may safely benefit from this minimally
invasive surgical approach. Indeed, previous studies on the
same subject not using axillary ultrasound in the preoperative
assessment, reported much higher reintervention rates,
ranging from 28% to 40% (19, 22). After the publication of
the ACOSOG Z0011 (29) and IBCSG 23-01 trials (30) and
the diffusion of the American Society of Clinical Oncology
clinical practice guideline updated in 2016 (31), pointing out
the futility of lymphadenectomy even in the presence of
metastases in the sentinel lymph node, the traditional concept
of ALND in breast cancer is currently questioned (32). The
utility of preoperative axillary ultrasound, as well as the
possibility of avoiding ALND, are currently being evaluated
in an ongoing prospective study promoted by Gentilini and
Veronesi (33).   
One of the most important outcomes of our study was
related to psychological issues. Using validated quality-of-
life-assessment tools, we obtained statistically significant
lower anxiety (p=0.05) and depression scores (p=0.01) in
patients who underwent a DS procedure in comparison with
patients having an overnight stay. Indeed, patients with
breast cancer have often a high grade of anxiety and
depression connected with their diagnosis and surgery (3-5).
Our findings support the hypothesis that early recovery in
the familial environment may contribute to decreased
anxiety, prevent the development of depression and feeling
of helplessness related to illness. It is also possible that
avoiding prolonged contact with other suffering oncologic
patients may aid in reducing patients’ anxiety and in
preserving their positive self-image. To our knowledge, this
is the first study to investigate the influence of early breast
cancer treatment in a DS setting on patients’ anxiety and
depression using validated questionnaires.  
The last relevant finding of our study was the economic
outcome. Early breast cancer treatment in a DS setting was
associated with savings of 49%. Obviously, the cost of the
operation was similar in outpatient and inpatient groups, but
the further 1-2 days of hospitalization as inpatients, added an
average cost of €530 per day. In the current series, even after
adjusting for costs due to reintervention, breast cancer
treatment in DS resulted in a potential savings of over
€60.000. Our results are in line with five previous studies
evaluating the economic outcomes of breast cancer treatment
in DS, which resulted to reduced costs with savings ranging
from 40% to 85%, compared to inpatient surgery (15, 19-22). 
In view of these several advantages, we believe that the
management of early breast cancer in DS warrants
encouragement. Our findings must be interpreted with caution
because of the non-randomized design of the study. Moreover,
psychological outcomes were evaluated in a relatively small
subgroup of early breast cancer patients treated with
conserving surgery and SLNB. Therefore, we cannot draw a
definitive conclusion. Nonetheless, our findings of improved
psychological outlooks for patients treated in DS are intriguing
and further studies on a larger scale of patients are warranted.
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